Related Experiment Video

Updated: Sep 3, 2026

Tissue Triage and Freezing for Models of Skeletal Muscle Disease
05:58

Tissue Triage and Freezing for Models of Skeletal Muscle Disease

Published on: July 15, 2014

Protein surplus myopathies and other rare congenital myopathies

Hans H Goebel1, Astrid Borchert

  • 1Department of Neuropathology, Johannes Gutenberg University Medical Center, Mainz, Germany.

Seminars in Pediatric Neurology
|July 26, 2002
PubMed

Insights

Protein surplus myopathies, a new subgroup of congenital myopathies, are characterized by protein aggregate accumulation. Molecular insights are redefining the classification of these rare muscle disorders.

Area of Science:

  • Neurology
  • Genetics
  • Pathology

Background:

  • Protein surplus myopathies are a newly identified group of congenital myopathies.
  • These myopathies are defined by the accumulation of protein aggregates, including mutant proteins.
  • Current classifications include desmin-related myopathies, actinopathies, and hereditary inclusion body myopathies, with hyaline body myopathy being a potential candidate.

Purpose of the Study:

  • To discuss the evolving nosologic and molecular criteria for protein surplus myopathies.
  • To highlight the impact of molecular advancements on the understanding and classification of congenital myopathies.
  • To introduce the ENMC Consortium's updated focus on protein surplus and other congenital myopathies.

Main Methods:

  • Review of current literature and nosologic criteria for protein surplus myopathies.
  • Analysis of molecular findings in congenital myopathies.
  • Discussion of ongoing research and consortium efforts.

Main Results:

  • Protein aggregate accumulation is a key feature of this myopathy subgroup.
  • Molecular data is crucial for accurate classification and understanding of congenital myopathies.
  • Existing classifications are being reassessed due to new molecular insights.

Conclusions:

  • Protein surplus myopathies represent a significant area of research within congenital myopathies.
  • Molecular diagnostics are essential for refining the classification and understanding of these rare muscle diseases.
  • The ENMC Consortium is expected to provide further advancements in this field.

More Related Videos

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy10:30

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy

Published on: May 24, 2016

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells09:39

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells

Published on: July 29, 2016

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...